Catalent Supports U.S. Launch of Phathom Pharmaceuticals ’ New Products...

Catalent today welcomed the recent announcement by Phathom Pharmaceuticals that the U.S. FDA has approved both VOQUEZNA™ TRIPLE PAK™ (vonoprazan tablets, amoxicillin capsules, clarithromycin tablets)...(PRWeb June 09, 2022)Read the full story at https://www.prweb.com/releases/catalent_supports_u_s_launch_of_phathom_pharmaceuticals_new_products_following_regulatory_approval/prweb18728261.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news